The National Comprehensive Cancer Network's clinical practice guideline on "Prostate cancer" (Version 1.2013) does not mention the use of focal laser ablation as a therapeutic option. Furthermore, there is a National Cancer Institute-sponsored phase II clinical trial on “MR Image Guided Therapy i...
cancer (OR: 1.28, p < 0.001) and specifically for significant prostate cancer (OR: 1.46, p < 0.001) in uni-variate analyses. However, multi-variate analyses using age, PSA, prostate volume, DRE and transrectal ultrasonography outcome, and previous biopsy (yes/no) showed that PSAV was not ...
Dr. Stephen Scionti is the most experienced HIFU physician in the U.S. using the alternative prostate cancer treatment for customized treatment.
The Financial Impact of Hypofractionated Radiation for Localized Prostate Cancer in the United StatesCPT Code, Description 77301, IMRT2 treatment planning 77263, treatment planning complex 77338, MLCc design for IMRT 77300, Basic Dose Calculation G6015, IMRT treatment delivery∗∗...
prostate tumors once a diagnosis has been established. This test is also an aid in the management of prostate cancer patients and in detecting metastatic or persistent disease in patients following treatment.HCPCS Codes (Alphanumeric, CPT © AMA)ICD-10-CM Codes Covered by Medicare Program
Metastatic prostate cancer remains a therapeutic challenge. Based on data of the STAMPEDE trial, patients with a low metastatic burden showed prolonged failure-free and overall survival when treated with prostate radio therapy (RT) in addition to standard of care (SOC). The objective of this study...
For prostate cancer patients undergoing radiation therapy, maintaining quality of life may be just as important as treating the cancer. SpaceOAR Hydrogel for prostate cancer Dr. Marcio Fagundes,Radiation Oncologist, describes his experience using SpaceOAR Hydrogel including clinical considerations,...
Prostate Cancer Screening, Clinical Outcomes for Cancer Drugs Granted Accelerated Approval, Lupus Review, and more Editor’s Summary by Anne Rentoumis Cappola, MD, ScM, Associate Editor of JAMA, the Journal of the American Medical Association, for the May 7, 2024, issue....
The testicular androgen biosynthesis is well understood, however, how cancer cells gauge dwindling androgen to dexterously initiate its de novo synthesis remained elusive. We uncover dual-phosphorylated form of sterol regulatory element-binding protein 1
Prostate cancer (PCa) is the most common malignancy in men. Despite aggressive therapy involving surgery and hormonal treatments, the recurrence and emergence of metastatic castration-resistant prostate cancer (CRPCa) remain a major challenge. Dysregulation of the transforming growth factor-β (TGF-β...